Vaccine Contract Manufacturing: a Niche Segment Poised to Become a Global Market by 2026

Mohali, Punjab, India, July 12, 2016 --(PR.com)-- Roots Analysis has announced the addition of the “Vaccine Contract Manufacturing Market, 2016-2026” report to its list of offerings. The report provides an extensive study of the current market landscape, future trends and opportunities related to vaccine contract manufacturing. It includes a discussion on some of the key drivers and potential growth areas that are likely to impact the future evolution of this market. It also features a multi-parameter analysis of the biopharmaceutical contract manufacturing organizations that are engaged in this domain.

Snehasish Das, the principal analyst, said, “Despite the associated challenges, CMOs offering vaccine development and manufacturing services have witnessed significant growth.Owing to the highly complex manufacturing protocols and stringent regulatory standards, a sizeable proportion of vaccine manufacturing is currently being outsourced to contract manufacturers.”

Among other things, the report covers:

-A detailed analysis of vaccine service providers based on parameters such as geographical location, scale of operation, type of expression systems employed and manufacturing capabilities.
-Insights on the growing number of collaborations, increasing investment activity, facility expansions and technological advances that have taken place in the recent past.
-Informed guidance on the likely size of the market over the next decade. The study also includes a discussion on the inherent potential of emerging players in low-income geographies, such as China and India, highlighting their growing share in the overall market.
-A detailed SWOT analysis highlighting the key benefits and the current challenges faced by stakeholders in the market.
-A discussion on future opportunities and trends highlighting important aspects such as adoption of innovative technologies and a shift towards strategic partnering.

Das added, “Driven by an increasing global demand and the rapidly expanding vaccine market, the vaccine contract manufacturing market is projected to grow at an annualized rate of 9.8%. We believe that service providers engaged in this domain should be able to leverage the high demand for vaccines to further strengthen their foothold in this market.”

The opinions and insights discussed in this report were influenced by discussions conducted with experts in this area. The report includes detailed company profiles of the following players:

Albany Molecular Research (AMRI)
Bharat Biotech
Catalent
Charles River Laboratories International
Cobra Biologics
Eurogentec
GreenPak Biotech
IDT Biologika
Lonza
Meridian Life Science
Sigma Aldrich Fine Chemicals (SAFC)
SynCo Bio Partners
WuXi AppTec

The report is likely to benefit several stakeholders involved in the vaccine development and manufacturing market. Key personnel who stand to benefit from the insights in this report include:

Investors
CXO level decision makers
R&D Managers
Business Intelligence / Scientific Analysts
Licensing / Portfolio Managers
Strategy Managers

For additional details, please visit
https://www.rootsanalysis.com/reports/view_document/vaccine-contract-manufacturing-market-2016-2026/132.html

or email sales@rootsanalysis.com

About Roots Analysis
Roots Analysis is a specialist market research company, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like us to help you with your growing business needs, get in touch at info@rootsanalysis.com